Home » Archive

Channels

Drug Development, News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy

Posted by sandiegobiotech February 3rd, 2012 .
No Comments
—San Diego’s Amylin Pharmaceuticals says Bydureon, its new once-a-week drug for treating Type 2 diabetes can hit the market as early as next month, after the FDA cleared Bydureon. The FDA rejected...

[[Click headline to continue reading.]] More...

Biotechnology, Conferences, Drug Discovery, Headline, SDBN Blog, Uncategorized »

Focus on San Diego: Life Science Conferences Spring 2012

Posted by Mary Canady January 31st, 2012 .
No Comments

Image courtesy of user leighty (Ryan Leighty) on Flickr

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be shared during these two months.  Our own Mary Canady will also be participating in a panel discussing on the triumphs and trials of Transitioning from Academia to Industry at the Annual meeting of the Biophysical Society on Tuesday, February 28, 2:30 PM – 4:00 PM.

We hope that you are planning on attending at least some of these events, and to help you plan your attendance, we outline below pertinent information about each conference:

Name Date LinkedIn event page Twitter account Twitter hashtag Tweetup or Event
2012 Society for Laboratory Automation & Screening 2/4- 2/9 http://linkd.in/uVMlgx @SLAS_org #SLAS2012 No*
Biophysical Society 56th Annual Meeting 2/25- 2/29 http://linkd.in/uwFbH6 @BiophysicalSoc #bps12 No*
IBC’s Biopharmaceutical Development & Production Week 2/27- 3/2 http://linkd.in/zg1JCT @ibcusa #BDPWeek No*
American Chemical Society 3/25- 3/29 http://linkd.in/AgWH30 @ACSNatlMtg #ACSSanDiego Follow @pidgirl for details
Experimental Biology 4/21- 4/25 http://linkd.in/taE6N6 @expbio #EB2012 TBD

*SDBN may host a tweetup if none will be planned by meeting organizers.  Stay tuned.

The spring will be exciting for science in San Diego, add our Google calendar to yours so you won’t miss out on any local events. We hope you can set aside some time to take advantage of the presence of these major conferences in our city, we’ll be posting updates if you can’t. Some of the conferences have free or reasonable exhibit hall passes, and we’ll also post after hours events on our Facebook page so you can do some networking.

Comprendia is giving free social media consultations for your life science business, contact us to schedule one while you’re in San Diego.

More...

Drug Development, News, Syndication, Xconomy »

Angry at the Genome

Posted by sandiegobiotech January 24th, 2012 .
No Comments
In 2004, I was an enthusiastic postdoctoral researcher in Eric Lander’s lab at the Broad Institute, with the job I had dreamed of since I was 10 years old. Growing up in Paducah, KY, I read Isaac...

[[Click headline to continue reading.]] More...

Drug Development, News, Syndication, Xconomy »

Angry at the Genome

Posted by sandiegobiotech January 24th, 2012 .
No Comments
In 2004, I was an enthusiastic postdoctoral researcher in Eric Lander’s lab at the Broad Institute, with the job I had dreamed of since I was 10 years old. Growing up in Paducah, KY, I read Isaac...

[[Click headline to continue reading.]] More...

Drug Development, News, Syndication, Xconomy »

In Life Sciences Partnerships, You Must be Smart from the Beginning

Posted by sandiegobiotech January 20th, 2012 .
No Comments
As early stage biotech startups advance their drug candidates into pre-clinical development, many must decide at some point whether to start working with a big pharmaceutical or biotech partner to...

[[Click headline to continue reading.]] More...

Diagnostics, News, Syndication, Xconomy »

San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More

Posted by sandiegobiotech January 12th, 2012 .
No Comments
There was a whole lot of life sciences news over the past week. Here’s my roundup. —Carlsbad-based Life Technologies (NASDAQ: LIFE) said it’s taking orders for a benchtop genome sequencer that can to...

[[Click headline to continue reading.]] More...

Biotechnology, News, Syndication, Xconomy »

Me-Too Drugs

Posted by sandiegobiotech January 11th, 2012 .
No Comments
[Editor's Note: We asked selected Xconomists a series of questions designed to zero in on the big issues of the year, including "What would you be willing to throw a punch over?"] The FDA is the easy...

[[Click headline to continue reading.]] More...

Biotechnology, News, Syndication, Xconomy »

Me-Too Drugs

Posted by sandiegobiotech January 11th, 2012 .
No Comments
[Editor's Note: We asked selected Xconomists a series of questions designed to zero in on the big issues of the year, including "What would you be willing to throw a punch over?"] The FDA is the easy...

[[Click headline to continue reading.]] More...

Biotechnology, News, Syndication, Xconomy »

The Situation at the FDA: We Are All to Blame

Posted by sandiegobiotech January 10th, 2012 .
No Comments
[Editor's Note: We asked selected Xconomists a series of questions designed to zero in on the big issues of the year, including "What would you be willing to throw a punch over?"] It takes a lot to...

[[Click headline to continue reading.]] More...

Biotechnology, News, Syndication, Xconomy »

Lack of Funding For Innovative Biotech Companies

Posted by sandiegobiotech January 9th, 2012 .
No Comments
[Editor's Note: We asked selected Xconomists a series of questions designed to zero in on the big issues of the year, including "What would you be willing to throw a punch over?"] The most important...

[[Click headline to continue reading.]] More...